Dare Bioscience Inc
Research Dare Bioscience Inc (DARE) on Bullrun: market cap USD 12.45M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDARE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 12.45M
- Financial periodQ1 2026
- RevenueUSD 1.16M
- Net income-USD 3.00M
- Free cash flow-USD 5.52M
- Gross margin53.5%
Valuation Snapshot
latest market cap is USD 12.45M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.03M | -USD 13.40M | -USD 10.27M | 71.3% | -1.2 | USD 24.71M | USD 2.66M | USD 2.84M |
| FY2024 | USD 9.78K | -USD 4.05M | USD 4.90M | 100.0% | -0.48 | USD 15.70M | USD 4.05K | -USD 6.01M |
| FY2023 | USD 2.81M | -USD 30.16M | -USD 39.49M | n/a | -4.15 | USD 10.48M | USD 1.40M | -USD 5.05M |
| FY2022 | USD 10.00M | -USD 30.95M | -USD 18.15M | n/a | -0.37 | USD 34.67M | USD 582.72K | USD 11.11M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 12.45M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 27.98M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 27.15M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 30.47M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 70.38M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 167.89M | n/a | n/a | n/a |
About Dare Bioscience Inc
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dare Bioscience Inc's market cap?
Dare Bioscience Inc's market capitalization is USD 12.45M.
What does Dare Bioscience Inc do?
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis.